TG Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TGTX for the last quarter is 63.47 M USD, and it's 44.35% higher compared to the previous quarter. The net income of Q1 24 is -10.71 M USD.